COVID-19 complicated by infective endocarditis or concomitant infection? a case report

Pan Afr Med J. 2022 Mar 31:41:263. doi: 10.11604/pamj.2022.41.263.29438. eCollection 2022.

Abstract

Coronavirus disease 2019 (COVID-19) is a global pandemic and public health emergency. With a high infectivity and dissemination rate, cardiovascular complications have been observed and associated with a poorer prognosis. COVID-19 appears to be both a risk and prognosis factor for infective endocarditis. In this report, we present the case of a 53-year-old woman with a non-productive cough, progressive dyspnea and fatigue, diagnosed with COVID-19 four weeks earlier. The patient was referred to our department displaying the same symptoms. She was diagnosed with infective endocarditis of the mitral valve based on clinical symptoms, as well as radiological and analytical investigations. The patient was given appropriate medical treatment before admission based on azithromycin, corticosteroids for two weeks, during the hospitalization, she underwent treatment with antibiotics based on Teicoplanin and gentamicin. Outcome was good; the disappearance of the vegetative lesion on the weekly transthoracic echocardiogram (TTE). This rare case highlights questions about considering other coexisting diagnoses as well as possible complications a long with COVID-19.

Keywords: COVID-19; SARS-CoV-2; case report; complication; infective endocarditis.

Publication types

  • Case Reports

MeSH terms

  • COVID-19* / complications
  • COVID-19* / diagnosis
  • Endocarditis* / complications
  • Endocarditis* / diagnosis
  • Endocarditis, Bacterial* / complications
  • Endocarditis, Bacterial* / diagnosis
  • Endocarditis, Bacterial* / drug therapy
  • Female
  • Humans
  • Middle Aged
  • Mitral Valve
  • Pandemics